Cargando…
Atherosclerosis: from biology to pharmacological treatment
A recent explosion in the amount of cardiovascular risk has swept across the globe. Primary prevention is the preferred method to lower cardiovascular risk. Lowering the prevalence of obesity is the most urgent matter, and is pleiotropic since it affects blood pressure, lipid profiles, glucose metab...
Autores principales: | Riccioni, Graziano, Sblendorio, Valeriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470030/ https://www.ncbi.nlm.nih.gov/pubmed/23097661 http://dx.doi.org/10.3724/SP.J.1263.2012.02132 |
Ejemplares similares
-
Dietary Fibers and Cardiometabolic Diseases
por: Riccioni, Graziano, et al.
Publicado: (2012) -
Leukotrienes as Modifiers of Preclinical Atherosclerosis?
por: Riccioni, Graziano, et al.
Publicado: (2012) -
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
por: Riccioni, Graziano, et al.
Publicado: (2009) -
Ivabradine: An Intelligent Drug for the Treatment of Ischemic Heart Disease
por: Riccioni, Graziano
Publicado: (2012) -
Marine Bioactives: Pharmacological Properties and Potential Applications against Inflammatory Diseases
por: D’Orazio, Nicolantonio, et al.
Publicado: (2012)